Back to User profile » Dr Stefan Walzer
Papers published by Dr Stefan Walzer:
Original Research
Cross-market cost-effectiveness analysis of erlotinib as first-line maintenance treatment for patients with stable non-small cell lung cancer
Vergnenègre A, Ray JA, Chouaid C, Grossi F, Bischoff HG, Heigener DF, Walzer S
ClinicoEconomics and Outcomes Research 2012, 4:31-37
Published Date: 26 January 2012
Original Research
Indirect treatment comparison of bevacizumab + interferon-α-2a vs tyrosine kinase inhibitors in first-line metastatic renal cell carcinoma therapy
Gerald HJ Mickisch, Björn Schwander, Bernard Escudier, et al
ClinicoEconomics and Outcomes Research 2011, 3:19-27
Published Date: 25 January 2011